You just read:

BioMarin Announces Positive Final Results from Placebo-Controlled Phase 3 Data in Children with Achondroplasia Treated with Vosoritide

News provided by

BioMarin Pharmaceutical Inc.

Dec 16, 2019, 08:15 ET